We know that improving access to evidence-based screening, early diagnosis and timely treatment is essential for avoiding mortality and morbidity for patients, wasting resources and increasing costs of late-stage care. So, why does equitable access to screening, earlier diagnosis and treatment remain slow? Our panel discusses improving access to screening, diagnosis and treatment emphasising the role of innovation and best practices